Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zippelius

Showing results (241-250 of 308) with videos related to

Pageof 31
Sort By:
Science Translational Medicine|September 17, 2025
PD-1-targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancerIrene Fusi, Clara Serger, Petra Herzig, et al.
Cancer Science|March 1, 2008
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcomeM Tinguely, B Jenni, A Knights, et al.
Nature Biomedical Engineering|June 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyondMar Guaza-Lasheras, Johanna Nimmerfroh, Dominic Schwarz, et al.
Cancers|May 28, 2022
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during LockdownLisa Kostner, Sara Elisa Cerminara, Gustavo Santo Pedro Pamplona, et al.
Cancer Immunology Research|July 29, 2016
Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant MelanomaSebastian Theurich, Sacha I Rothschild, Michael Hoffmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigenPierre-Yves Dietrich, Frédérique-Anne Le Gal, Valérie Dutoit, et al.
Oncoimmunology|April 9, 2016
Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptorJens Schreiner, Daniela S Thommen, Petra Herzig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patientsSenta M Walton, Marco Gerlinger, Olga de la Rosa, et al.
Nature Medicine|July 9, 2021
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancerPaula Voabil, Marjolein de Bruijn, Lisanne M Roelofsen, et al.
Immunological Reviews|November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanomaPedro Romero, Danila Valmori, Mikael J Pittet, et al.
Pageof 31

Showing results (241-250 of 308) with videos related to

Sort By:
Pageof 31
Science Translational Medicine|September 17, 2025
PD-1-targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancerIrene Fusi, Clara Serger, Petra Herzig, et al.
Cancer Science|March 1, 2008
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcomeM Tinguely, B Jenni, A Knights, et al.
Nature Biomedical Engineering|June 29, 2026
The evolving role of cytokines for CAR-T cell manufacturing and beyondMar Guaza-Lasheras, Johanna Nimmerfroh, Dominic Schwarz, et al.
Cancers|May 28, 2022
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during LockdownLisa Kostner, Sara Elisa Cerminara, Gustavo Santo Pedro Pamplona, et al.
Cancer Immunology Research|July 29, 2016
Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant MelanomaSebastian Theurich, Sacha I Rothschild, Michael Hoffmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigenPierre-Yves Dietrich, Frédérique-Anne Le Gal, Valérie Dutoit, et al.
Oncoimmunology|April 9, 2016
Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptorJens Schreiner, Daniela S Thommen, Petra Herzig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patientsSenta M Walton, Marco Gerlinger, Olga de la Rosa, et al.
Nature Medicine|July 9, 2021
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancerPaula Voabil, Marjolein de Bruijn, Lisanne M Roelofsen, et al.
Immunological Reviews|November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanomaPedro Romero, Danila Valmori, Mikael J Pittet, et al.
Pageof 31